Fadi Agour

Ultra-processed foods (UPFs) have become a cornerstone of modern diets, but their convenience comes at a cost. As consumption of these foods has skyrocketed, so too have the alarming health complications linked to them, including obesity, diabetes, heart disease, and even certain cancers. This growing public health crisis has sparked a wave of litigation against …

The Ultra-Processed Foods Lawsuit: A Must-Know Update for Mass Tort Lawyers Read More »

What is BioZorb? The BioZorb litigation is shaping up to be one of the most significant legal challenges of 2025, presenting a unique opportunity for plaintiff attorneys nationwide. This case revolves around a medical device designed to aid breast cancer patients but has since been linked to serious complications, sparking widespread litigation. As the legal …

Understanding the BioZorb Litigation: A Growing Legal Battle for Plaintiff Attorneys Read More »

 A Growing Need for High-Quality Roundup Claimants As Roundup litigation continues to unfold, the volume of claims related to its potential link to Non-Hodgkin’s Lymphoma (NHL) continues to grow. This has led to an increasing demand for claimant leads that are not only legitimate but also meet specific criteria set by law firms. The challenge, …

Best Practices for Screening Roundup Claimants: Ensuring Quality and Preventing Fraud in Mass Tort Cases Read More »

Oxbryta Litigation: A Deep Dive into the Legal Challenges and Industry Implications.   The recent recall of Oxbryta (voxelotor), a medication designed to treat sickle cell disease (SCD), has led to a wave of legal challenges that are reverberating throughout the pharmaceutical industry. Initially heralded as a breakthrough treatment for SCD, Oxbryta was approved by …

Oxbryta Litigation Read More »